ErbB receptors: from oncogenes to targeted cancer therapiesHongtao Zhang, Mark I. Greene, Alan Berezov et al.|Journal of Clinical Investigation|2007Cited by 578
Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivoByeong‐Woo Park, Ramachandran Murali, Hongtao Zhang et al.|Nature Biotechnology|2000Cited by 200
YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14J-M Huang, Qiang Wang, Izumi Nagatomo et al.|Oncogene|2012Cited by 151
Structure of Sad1-UNC84 Homology (SUN) Domain Defines Features of Molecular Bridge in Nuclear EnvelopeZhaocai Zhou, Qiang Wang, Hongtao Zhang et al.|Journal of Biological Chemistry|2011Cited by 136
Disabling ErbB Receptors with Rationally Designed Exocyclic Mimetics of Antibodies: Structure−Function AnalysisAlan Berezov, Ramachandran Murali, Hongtao Zhang et al.|Journal of Medicinal Chemistry|2001Cited by 107